NCT04309643View on ClinicalTrials.gov

Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

June 25, 2020

Study Completion Date

July 8, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

CTP-543

Investigational Drug

DRUG

Combined oral contraceptive containing Ethinyl estradiol (EE) and Levonorgestrel (LNG)

Oral contraceptive in the form of 1 fixed combination tablet of Seasonique or generic equivalent (0.03 mg EE / 0.15 mg LNG)

Trial Locations (1)

85283

Celerion, Inc., Tempe

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Concert Pharmaceuticals

INDUSTRY

NCT04309643 - Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects | Biotech Hunter | Biotech Hunter